Compare Liberty Global Ltd Class C (LBTYK) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liberty Global Ltd Class C vs State Street SPDR S&P Biotech ETF — how do they compare? Liberty Global Ltd Class C trades at $9.98 (market cap $3.48B), while State Street SPDR S&P Biotech ETF trades at $158.17. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals.
| LBTYK | XBI | |
|---|---|---|
Market Cap | $3.48B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $12.67 | $164.28 |
52-Week Low | $9.59 | $86.92 |
Enterprise Value | $10.13B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
